These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
780 related articles for article (PubMed ID: 35090388)
1. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine. Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study. Muhsen K; Maimon N; Mizrahi A; Bodenheimer O; Cohen D; Maimon M; Grotto I; Dagan R Clin Infect Dis; 2022 Aug; 75(1):e755-e763. PubMed ID: 34698808 [TBL] [Abstract][Full Text] [Related]
3. Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization. Bonura F; De Grazia S; Bonura C; Sanfilippo GL; Giammanco GM; Amodio E; Ferraro D J Appl Microbiol; 2022 May; 132(5):3987-3994. PubMed ID: 35083832 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine. Yavuz E; Günal Ö; Başbulut E; Şen A J Med Virol; 2022 Aug; 94(8):3768-3775. PubMed ID: 35434796 [TBL] [Abstract][Full Text] [Related]
5. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy. Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489 [TBL] [Abstract][Full Text] [Related]
6. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers. Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048 [TBL] [Abstract][Full Text] [Related]
7. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy). Basso P; Negro C; Cegolon L; Larese Filon F Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930 [No Abstract] [Full Text] [Related]
8. COVID-19 Immunity in the Cohort of IRCCS San Raffaele Hospital Employees after BNT162b2 Vaccination: A Retrospective Observational Study. Stocchi M; Melodia P; Lucini A; De Lorenzo R; Pozzi C; Rovere-Querini P; Odone A; Renzi C; Signorelli C Ann Ig; 2024; 36(4):432-445. PubMed ID: 38386027 [TBL] [Abstract][Full Text] [Related]
9. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study]. Özgür D; Tütüncü EE Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958 [TBL] [Abstract][Full Text] [Related]
10. Primary series COVID-19 vaccine effectiveness among health care workers in the country of Georgia, March-December 2021. Katz MA; Rojas Castro MY; Chakhunashvili G; Chitadze N; Ward CL; McKnight CJ; Lucaccioni H; Finci I; Zardiashvili T; Pebody R; Kissling E; Sanodze L PLoS One; 2024; 19(9):e0307805. PubMed ID: 39240827 [TBL] [Abstract][Full Text] [Related]
11. Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy. Milazzo L; Pezzati L; Oreni L; Kullmann C; Lai A; Gabrieli A; Bestetti G; Beschi C; Conti F; Ottomano C; Gervasoni C; Meroni L; Galli M; Antinori S; Ridolfo AL Hum Vaccin Immunother; 2021 Dec; 17(12):4747-4754. PubMed ID: 35086438 [TBL] [Abstract][Full Text] [Related]
12. An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status. Lumley SF; Rodger G; Constantinides B; Sanderson N; Chau KK; Street TL; O'Donnell D; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Warren F; Peck LJ; Ritter TG; de Toledo Z; Warren L; Axten D; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Chand M; Crook DW; O'Donnell AM; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Hopkins S; Walker TM; Stoesser NE; Matthews PC; Jeffery K; Eyre DW; Clin Infect Dis; 2022 Apr; 74(7):1208-1219. PubMed ID: 34216472 [TBL] [Abstract][Full Text] [Related]
13. Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response. Ontañón J; Blas J; de Cabo C; Santos C; Ruiz-Escribano E; García A; Marín L; Sáez L; Beato JL; Rada R; Navarro L; Sainz de Baranda C; Solera J EBioMedicine; 2021 Nov; 73():103656. PubMed ID: 34740112 [TBL] [Abstract][Full Text] [Related]
14. Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020-2022): A retrospective longitudinal SARS-CoV-2 serological surveillance. De Pace V; Bruzzone B; Ricucci V; Calcavecchia N; Guarona G; Giberti I; Costa E; Ogliastro M; Galano B; Nigro N; Murgia D; Nanni L; Orsi A Hum Vaccin Immunother; 2023 Aug; 19(2):2258632. PubMed ID: 37724517 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Antibody Response to the BNT162b2 mRNA Vaccine in Persons with Past Natural Infection. Kang YM; Choe KW; Lee KD; Kim KN; Kim MJ; Lim J J Korean Med Sci; 2021 Sep; 36(35):e250. PubMed ID: 34490757 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data. Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462 [TBL] [Abstract][Full Text] [Related]
17. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study. Moscara L; Venerito V; Martinelli A; Di Lorenzo A; Toro F; Violante F; Tafuri S; Stefanizzi P Vaccine; 2023 Aug; 41(38):5655-5661. PubMed ID: 37544827 [TBL] [Abstract][Full Text] [Related]
18. Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers. Ioannou P; Karakonstantis S; Astrinaki E; Saplamidou S; Vitsaxaki E; Hamilos G; Sourvinos G; Kofteridis DP Infect Dis (Lond); 2021 Nov; 53(11):876-879. PubMed ID: 34176397 [TBL] [Abstract][Full Text] [Related]
19. Antibody responses and SARS-CoV-2 infection after BNT162b2 mRNA booster vaccination among healthcare workers in Japan. Igari H; Asano H; Murata S; Yoshida T; Kawasaki K; Kageyama T; Ikeda K; Koshikawa H; Okuda Y; Urushihara M; Chiba H; Yahaba M; Taniguchi T; Matsushita K; Yoshino I; Yokote K; Nakajima H J Infect Chemother; 2022 Nov; 28(11):1483-1488. PubMed ID: 35870791 [TBL] [Abstract][Full Text] [Related]
20. Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia. Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I Int J Infect Dis; 2021 Dec; 113():15-17. PubMed ID: 34614445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]